Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA Sequencing analysis of xenografts for mouse gene expression changes

ABSTRACT: RNA Sequencing analysis of xenografts for mouse gene expression changes

PROVIDER: PRJNA559355 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9931562_1.fastq.gz	Fastqsanger.gz
	SRR9931562_2.fastq.gz	Fastqsanger.gz
	SRR9931563_1.fastq.gz	Fastqsanger.gz
	SRR9931563_2.fastq.gz	Fastqsanger.gz
	SRR9931564_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

RNA Sequencing analysis of xenografts for mouse gene expression changes

Project description:Control and 2G8-treated MiaPaca-2 and Colo375 xenografts were subjected to RNA-seq analysis for mouse gene expression changes

2019-10-08 | GSE135578 | GEO

Single-cell analysis reveals dynamic changes of A549 cells in monolayer, A549 xenografts in nude mice, and xenografts after exposure to dacomitinib

Project description:The in vitro A549 cells, and A549 xenografts in nude mouse were two classic and commonly used models for anti-cancer drug discovery. Here dynamic changes of the A549 models, and also A549 xenografts after exposure to dacomitinib were revealed by single-cell transcriptome analysis.

2023-12-01 | GSE220435 | GEO

mRNA sequencing of mouse melanoma xenografts with micro-domain sAC expression

Project description:Transcriptome sequencing of mouse melanoma xenografts containing micro-domain localized sAC under control of doxycycline.

2021-10-11 | GSE159362 | GEO

mRNA sequencing of mouse melanoma xenografts with micro-domain sAC expression

Project description:mRNA sequencing of mouse melanoma xenografts with micro-domain sAC expression

| PRJNA668617 | ENA

Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

Project description:Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

| PRJNA478619 | ENA

Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

Project description:Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

| PRJNA478618 | ENA

Analysis of genetic changes in MCF10A series cells and MCFDCIS derived xenografts

Project description:MCF10A series is one of the few human models of breast tumor progression. A derivative of MCF10A cells is the MCFDCIS, which reproducibly forms comedo DCIS-like lesions that spontaneously progress to invasive tumors. We used this model to explore the relative importance of myoepithelial cells and stromal fibroblasts in the in situ to invasive breast carcinoma transition. We use Affymetrix 11K XbaI or 250K StyI SNP arrays to analyze the MCF10A series cells and MCFDCIS derived xenografts for copy number changes and LOH (loss of heterozygosity). Keywords: Cell line, xenografts of time course/co-injection groups, different cell types isolated from xenografts

2008-03-07 | GSE10747 | GEO

Gene expression changes during development of sunitinib resistance in renal cell carcinoma patient derived xenografts

Project description:Gene expression changes during development of sunitinib resistance in renal cell carcinoma patient derived xenografts

| PRJNA306151 | ENA

Microarray analysis of mouse gene expression in metronomic cyclophosphamide-treated human glioma U251 xenografts implanted in scid mice

Project description:Cyclophosphamide (CPA) treatment on a six-day repeating metronomic schedule induces a dramatic, innate immune cell-dependent regression of implanted gliomas. However, little is known about the underlying mechanisms of innate immune cell mobilization and recruitment, or about the role of DNA damage and cell stress response pathways in eliciting the anti-tumor immune responses linked to tumor regression. To address these questions, we compared untreated and 6-day metronomic cyclophosphamide-treated human U251 glioblastoma xenografts by mouse microarray analysis to identify responsive mouse (host) cell-specific factors.

2015-05-04 | GSE60866 | GEO

Microarray analysis of mouse gene expression in metronomic cyclophosphamide-treated rat glioma 9L xenografts implanted in scid mice

Project description:Cyclophosphamide (CPA) treatment on a six-day repeating metronomic schedule induces a dramatic, innate immune cell-dependent regression of implanted gliomas. However, little is known about the underlying mechanisms of innate immune cell mobilization and recruitment, or about the role of DNA damage and cell stress response pathways in eliciting the anti-tumor immune responses linked to tumor regression. To address these questions, we compared untreated and 6-day metronomic cyclophosphamide-treated rat 9L gliosarcoma xenografts by mouse microarray analysis to identify responsive mouse (host) cell-specific factors.

2015-05-04 | GSE60864 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data